Literature DB >> 12631115

Gene transfer of truncated IkappaBalpha prevents tubulointerstitial injury.

Osamu Takase1, Junichi Hirahashi, Atsushi Takayanagi, Akihiro Chikaraishi, Takeshi Marumo, Yuri Ozawa, Matsuhiko Hayashi, Nobuyoshi Shimizu, Takao Saruta.   

Abstract

BACKGROUND: Severe proteinuria not only indicates the presence of progressive glomerular disease, but also causes tubular epithelial cells to produce inflammatory mediators leading to tubulointerstitial (TI) injury. We investigated the role of nuclear factor-kappaB (NF-kappaB) in tubular epithelial cells in the development of proteinuria-induced TI injury.
METHODS: To specifically inhibit NF-kappaB activation, a recombinant adenovirus vector expressing a truncated form of IkappaBalpha (AdexIkappaBDeltaN) was injected into renal arteries of protein-overloaded rats, a model of TI injury characterized by infiltration of mononuclear cells and fibrosis.
RESULTS: Activation of NF-kappaB in the renal cortex, observed in protein-overloaded rats treated with a control vector, recombinant lacZ adenovirus, was prevented in AdexIkappaBDeltaN-injected rats. Microscopic examination revealed AdexIkappaBDeltaN treatment to markedly attenuate proteinuria-induced TI injury. Increased immunostaining of vascular cell adhesion molecule-1, transforming growth factor-beta, and fibronectin in TI lesions also was suppressed by AdexIkappaBDeltaN injection.
CONCLUSIONS: These findings provide evidence of the critical role of NF-kappaB activation in TI injury and suggest the therapeutic potential of adenovirus-mediated IkappaBDeltaN gene transfer into the kidney as a means of interrupting the process of TI damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631115     DOI: 10.1046/j.1523-1755.2003.00781.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

1.  Fibroblast expression of an IκB dominant-negative transgene attenuates renal fibrosis.

Authors:  Tsutomu Inoue; Tsuneo Takenaka; Matsuhiko Hayashi; Toshiaki Monkawa; Jun Yoshino; Kouji Shimoda; Eric G Neilson; Hiromichi Suzuki; Hirokazu Okada
Journal:  J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 10.121

2.  Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.

Authors:  Yuri Ozawa; Hiroyuki Kobori; Yuki Suzaki; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2006-06-27

3.  Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.

Authors:  Maho Yamashita; Tadashi Yoshida; Sayuri Suzuki; Koichiro Homma; Matsuhiko Hayashi
Journal:  Clin Exp Nephrol       Date:  2016-04-18       Impact factor: 2.801

Review 4.  Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.

Authors:  Q Ping Dou; Jeffrey A Zonder
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

Review 5.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

6.  Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis.

Authors:  Ling Zheng; Raja Sinniah; Stephen I-Hong Hsu
Journal:  J Histochem Cytochem       Date:  2008-02-18       Impact factor: 2.479

7.  NF-kappaB-dependent genes induced by proteinuria and identified using DNA microarrays.

Authors:  Osamu Takase; Takeshi Marumo; Keiichi Hishikawa; Toshiro Fujita; Richard J Quigg; Matsuhiko Hayashi
Journal:  Clin Exp Nephrol       Date:  2008-02-15       Impact factor: 2.801

8.  A20 overexpression alleviates pristine-induced lupus nephritis by inhibiting the NF-κB and NLRP3 inflammasome activation in macrophages of mice.

Authors:  Min Li; Xiaowei Shi; Tian Qian; Jian Li; Zhiqiang Tian; Bing Ni; Fei Hao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling.

Authors:  Myrto Giannopoulou; Chunsun Dai; Xiaoyue Tan; Xiaoyan Wen; George K Michalopoulos; Youhua Liu
Journal:  Am J Pathol       Date:  2008-05-23       Impact factor: 4.307

10.  Treatment with pyrrolidine dithiocarbamate improves proteinuria, oxidative stress, and glomerular hypertension in overload proteinuria.

Authors:  Edilia Tapia; Dolores J Sánchez-González; Omar N Medina-Campos; Virgilia Soto; Carmen Avila-Casado; Claudia M Martínez-Martínez; Richard J Johnson; Bernardo Rodríguez-Iturbe; José Pedraza-Chaverrí; Martha Franco; Laura G Sánchez-Lozada
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.